CD274 and melanoma: Multiple solid tumor types including melanoma, renal cell carcinoma, non-small cell lung carcinoma, thymoma, ovarian, and colorectal cancer co-opt this immune shield by expressing PDL-1 to generate an immunosuppressive tumor microenvironment and avoid T cell cytolysis.